Layla Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.8/10
Best for: brand-name GLP-1s bought cash with a monthly subscription
Layla scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. Its compounded semaglutide costs $237 a month, 19% above the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
then $237/mo ongoing
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Layla's lineup is now mostly brand-name GLP-1s, sold cash: Ozempic and Mounjaro at $1,399, Zepbound at $1,599 for new customers, Wegovy at $1,699. Its one cheaper product is oral semaglutide drops at $237 a month after a $187 first month, sold from a page the treatment menu no longer lists. Compounded tirzepatide is gone. Dynamic Trading Enterprises LLC runs it, with Beluga Health physicians reviewing an online intake. Subscriptions cancel anytime on 30 days' notice.
Is Layla legit?
Yes. Layla is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.8/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Layla promo or coupon code?
Layla has no coupon code to enter. New patients are currently quoted $187 for the first month, then $237 a month, and the discount applies on its own. Coupon sites advertising a "Layla promo code" are not a source we can vouch for.
See how Layla compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Layla
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
AgelessRx
Best for: microdosed compounded GLP-1s from a longevity clinic, or brand Wegovy at manufacturer pricing plus monitoring
Editorial score · methodology
Layla at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Ozempic, Wegovy, Zepbound, Mounjaro, Oral semaglutide drops
- Starting price
- $237/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How Layla scores
Six columns, each one computed from something Layla has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.7/10$237/month is 19% above the $199 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Layla
Last checked October 2026- Checked the listed price across 5 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Layla
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Layla involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Layla shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Layla which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $237, tirzepatide $1,399. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Layla serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Layla
- Phone
- 0207 427 6085
- Layla offers email support
Cancelling Layla
Taken from the terms Layla publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None; 30 days' notice
- Refund policy
- If a sent prescription order can be canceled, a $100 visit and clinical fee is kept
- Early-termination fee
- None
Medications Layla lists
Layla lists Wegovy, Ozempic, Zepbound, Mounjaro and compounded semaglutide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
$187 first month, then $237/month. Visit, medication and check-ins included. Page is not linked from the treatment menu.
Listed $1,499 with $100 off applied automatically.
Listed $1,799 with $100 off applied automatically.
Listed $1,499 with $100 off applied automatically.
$100 off for new customers only.
Check the price yourself before you pay
Every figure here comes from Layla's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $1,399 a month, close to the $1,299 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Layla
Against it
- Semaglutide costs $237 a month, 19% above the $199 median for compounded semaglutide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its compounded semaglutide is not FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Layla charges
Layla advertises $187. That buys the first month. The standing rate is $237/month, and that is the one worth doing the math on, because the introductory figure applies once.
- Compounded semaglutide: $187 first month, then $237/month
- Ozempic: $1,399/month
- Wegovy: $1,699/month
- Mounjaro: $1,399/month
- Zepbound: $1,599 promotional price, regular $1,699/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Layla's $237 is a premium, and a premium has to buy something. Discounting the first month does not change the twelve-month total by much. Before you pay, compare Layla's cancellation terms with other sellers' cancellation and refund policies. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
Belle Health dispenses semaglutide and tirzepatide from $199/month, which makes it the fair comparison to run before you commit here.
What Layla dispenses
Layla prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. You can take the approved brand pen or the cheaper compounded preparation. What separates them is review: the approved product went through it, the compounded one did not, and that is the whole of the trade. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Layla at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot. No human absorption study of sublingual semaglutide drops has been published.
Safety and disclosure
Layla tells you its price before you start the medical questionnaire. It also offers clinician messaging between visits. We found no FDA warning letters issued to Layla. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Layla will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
- You would be choosing on the advertised figure. The introductory month is real, but it is not what you will pay in month three.
- You need insurance to cover the cost. Check whether Layla bills your plan before you start.
It fits if
- you want a cheap way to find out whether the medication suits you before committing
- injections are the thing keeping you from starting
- reaching a clinician between visits matters to you
Our read
Layla is a cheap way to start and an ordinary way to continue. Use the $187 month for what it is good for, finding out whether the medication works for you, and re-run the numbers against $237/month before you let it renew twice. Wellorithm is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Layla scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. Its compounded semaglutide costs $237 a month, 19% above the $199 median among the sellers we compare.
Before you pay Layla
Starting at $237 a month. Check today's price, then start the intake.
Where Layla is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider WellMedRx (from $49/mo).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Layla sets more sellers in the same category beside Layla on price, states and what the price includes.
Frequently Asked Questions
How to check Layla yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Layla review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Layla's current pricing
Plans start at $187 a month. Whether you qualify is a clinician's decision, made after your intake.